Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Given Average Rating of “Hold” by Brokerages
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) has earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the firm, MarketBeat.com reports. Six research analysts have rated the...








